Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.

Guo, X.,Koff, J. L.,Moffitt, A. B.,Cinar, M.,Ramachandiran, S.,Chen, Z.,Switchenko, J. M.,Mosunjac, M.,Neill, S. G.,Mann, K. P.,Bagirov, M.,Du, Y.,Natkunam, Y.,Khoury,...; Oncogene. 2017 Apr 04.

Relations Between Residential Proximity to EPA-Designated Toxic Release Sites and Diffuse Large B-Cell Lymphoma Incidence.

Bulka C, Nastoupil LJ, Koff JL, Bernal-Mizrachi L, Ward KC, Williams JN, Bayakly AR, Switchenko JM, Waller LA, Flowers CR; South. Med. J.. 2016-10-01.

Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma.

Chen, Q.,Ayer, T.,Nastoupil, L. J.,Koff, J. L.,Staton, A. D.,Chhatwal, J.,Flowers, C. R.,Chen, Q.,Ayer, T.,Nastoupil, L. J.,Koff, J. L.,Staton, A. D.,Chhatwal, J.,Flow...; Leuk. Lymphoma. 2015 Sep 29.